Cargando…

Emerging biomarkers for checkpoint inhibitors in thymic epithelial tumors

Detalles Bibliográficos
Autores principales:	Owen, Dwight H., Otterson, Gregory A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794308/ https://www.ncbi.nlm.nih.gov/pubmed/35129545 http://dx.doi.org/10.21037/med.2019.01.02

Ejemplares similares

Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors
por: Tateo, Valentina, et al.
Publicado: (2020)

Immune checkpoints in thymic epithelial tumors: challenges and opportunities
por: Girard, Nicolas
Publicado: (2019)

Immune checkpoint inhibitors for treatment of thymic epithelial tumors: how to maximize benefit and optimize risk?
por: Zhao, Chen, et al.
Publicado: (2019)

Association Between RBC Antigen Allo-Antibodies and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Treatment for Advanced Cancers
por: Jain, Natasha A, et al.
Publicado: (2020)

Emerging therapies in thymic epithelial tumors (Review)
por: Dapergola, Athina, et al.
Publicado: (2023)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
por: Jiang, Ben‐Yuan, et al.
Publicado: (2021)

Adiponectin‐expressing Treg cells in experimental thymic tumor model
por: Hanamatsu, Yuki, et al.
Publicado: (2023)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
por: Takada, Kazuki, et al.
Publicado: (2021)

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
por: Jiang, Tao, et al.
Publicado: (2020)

Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma
por: Kaira, Kyoichi, et al.
Publicado: (2021)

Searching for Novel Biomarkers in Thymic Epithelial Tumors: Immunohistochemical Evaluation of Hippo Pathway Components in a Cohort of Thymic Epithelial Tumors
por: Palamaris, Kostas, et al.
Publicado: (2023)

Immune checkpoint inhibitors: friend or foe for osteoporosis
por: Tang, Jun
Publicado: (2023)

Efficacy and safety of immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy for thymic epithelial tumors (TETs): a retrospective study
por: Xiang, Jing, et al.
Publicado: (2023)

Epigenetics of Thymic Epithelial Tumors
por: Nicolì, Vanessa, et al.
Publicado: (2023)

The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors
por: Jin, Ying, et al.
Publicado: (2020)

Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
por: Abushukair, Hassan Mohammed, et al.
Publicado: (2022)

High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy
por: Falchi, Lorenzo, et al.
Publicado: (2016)

Emerging treatment options for patients with recurrent advanced thymic epithelial tumors
por: Evans, Tracey L
Publicado: (2012)

Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer
por: Johns, Andrew C, et al.
Publicado: (2023)

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
por: Haddad, Tyler C., et al.
Publicado: (2021)

Thymic Carcinoma Developing Years after Thymectomy
por: Ghorbani-Abdehgah, Ali, et al.
Publicado: (2017)

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2019)

Rechallenge in Immune Checkpoint Inhibitors Associated Renal Tubular Acidosis
por: Shah, Chintan V., et al.
Publicado: (2023)

The Promising Link Among Tumor Mutational Burden, Immune-Related Adverse Events, and Immune Checkpoint Inhibitors Efficacy in SCLC
por: Cortellini, Alessio
Publicado: (2020)

Deciphering the biology of thymic epithelial tumors
por: Rajan, Arun, et al.
Publicado: (2019)

Thymic Epithelial Tumors: An Evolving Field
por: Kuhn, Elisabetta, et al.
Publicado: (2023)

Growth of thymic epithelial tumors and thymic cysts: Differential radiological points
por: Kim, Hyungjin, et al.
Publicado: (2019)

Expression of RAGE and HMGB1 in Thymic Epithelial Tumors, Thymic Hyperplasia and Regular Thymic Morphology
por: Moser, Bernhard, et al.
Publicado: (2014)

Significant Differences in Thymic Index of Thalassemia Major Patients
por: Oymak, Yeşim, et al.
Publicado: (2014)

Osteonecrosis of the jaw induced by immune checkpoint inhibitors: an urgent need for attention
por: Li, Xinya, et al.
Publicado: (2023)

A Review of Emerging Biomarkers for Immune Checkpoint Inhibitors in Tumors of the Gastrointestinal Tract
por: Liao, Xuqiang, et al.
Publicado: (2022)

The predictive value of tumor mutation burden for immune checkpoint inhibitors therapy in non-small cell lung cancer is affected by patients’ age
por: Wu, Yongfeng, et al.
Publicado: (2020)

Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19
por: Trojaniello, C., et al.
Publicado: (2021)

Immune checkpoint inhibitor-induced encephalitis with dostarlimab in two patients: Case series
por: Marzoughi, Sina, et al.
Publicado: (2021)

Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers
por: Li, Anlin, et al.
Publicado: (2020)

The immune checkpoints storm in COVID‐19: Role as severity markers at emergency department admission
por: Avendaño‐Ortiz, José, et al.
Publicado: (2021)

Bioinformatics analysis of the key potential ceRNA biomarkers in human thymic epithelial tumors
por: Chen, Kegong, et al.
Publicado: (2021)

Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors
por: Palamaris, Kostas, et al.
Publicado: (2023)

Novel Biologic Therapies for Thymic Epithelial Tumors
por: Chen, Yuanbin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lc6513tu2c2k9fqvct1g6mevgc